The BRAF is the most prevalent mutation in thyroid cancer, which occurs in more than 50% of papillary thyroid cancers (PTCs) and approximately 45% of anaplastic thyroid cancer [18]. The gene discussed is BRAF; the disease is thyroid gland carcinoma.